keyword
https://read.qxmd.com/read/38565263/a-comprehensive-histomolecular-characterization-of-meningioangiomatosis-further-evidence-for-a-precursor-neoplastic-lesion
#21
JOURNAL ARTICLE
Arnault Tauziède-Espariat, Julien Masliah-Planchon, Philipp Sievers, Felix Sahm, Volodia Dangouloff-Ros, Nathalie Boddaert, Lauren Hasty, Oumaima Aboubakr, Alice Métais, Fabrice Chrétien, Alexandre Roux, Johan Pallud, Thomas Blauwblomme, Kévin Beccaria, Franck Bourdeaut, Stéphanie Puget, Pascale Varlet
Meningioangiomatosis (MAM) remains a poorly understood lesion responsible for epileptic disease. In the past, MAM was primarily described in the context of neurofibromatosis type 2 before being mainly reported sporadically. Moreover, the malformative or tumoral nature is still debated. Because a subset of MAM are associated with meningiomas, some authors argue that MAM corresponds to an infiltration pattern of these tumors. For these reasons, MAM has not been added to the World Health Organization (WHO) Classification of Central Nervous System Tumors as a specific entity...
April 2, 2024: Brain Pathology
https://read.qxmd.com/read/38564963/intraoperative-assessment-of-cochlear-nerve-functionality-in-various-vestibular-schwannoma-scenarios-lessons-learned
#22
JOURNAL ARTICLE
Luis Lassaletta, Miryam Calvino, Miguel Díaz, José Manuel Morales-Puebla, Isabel Sánchez-Cuadrado, Isabel Varela-Nieto, Javier Gavilán
The use of cochlear implants (CIs) is on the rise for patients with vestibular schwannoma (VS). Besides CI following tumor resection, new scenarios such as implantation in observed and/or irradiated tumors are becoming increasingly common. A significant emerging trend is the need of intraoperative evaluation of the functionality of the cochlear nerve in order to decide if a CI would be placed. The purpose of this paper is to explore the experience of a tertiary center with the application of the Auditory Nerve Test System (ANTS) in various scenarios regarding VS patients...
March 23, 2024: Hearing Research
https://read.qxmd.com/read/38554009/cochlear-implant-outcomes-in-patients-with-intralabyrinthine-schwannoma-a-scoping-review
#23
REVIEW
Katherine Wang, Emily K Gjini, Sarah Kooper-Johnson, Michael I Cooper, Collyn Gallant, Kathryn Y Noonan
OBJECTIVE: To evaluate the literature and summarize cochlear implantation (CI) outcomes after intralabyrinthine schwannoma (ILS) excision and tumor observation with CI. DATA SOURCES: OVID Medline, Embase, Web of Science; conception to 2024. REVIEW METHODS: A literature review was performed using subject headings, MeSH terms, and keywords. Abstracts and full texts were reviewed by two independent reviewers and adjudicated by a third. Inclusion criteria included studies with ILS and CI with reported audiologic outcomes...
March 30, 2024: Laryngoscope
https://read.qxmd.com/read/38552238/association-of-frequent-nf2-mutations-with-spinal-location-predominance-and-worse-outcomes-in-psammomatous-meningiomas
#24
JOURNAL ARTICLE
Leihao Ren, Qing Xie, Jiaojiao Deng, Jiawei Chen, Jinxiu Yu, Daijun Wang, Hiroaki Wakimoto, Ye Gong, Lingyang Hua
OBJECTIVE: Psammomatous meningiomas (PMs) are a rare histological subtype of meningioma but are rather frequent in spinal meningiomas. The authors aimed to analyze the incidence, clinical features, molecular alterations, long-term outcomes, and prognostic factors of PMs. METHODS: In total, 151 patients with PMs were included in this study. Clinical characteristics, molecular alterations, and progression-free survival (PFS) were analyzed in PMs. Clinical characteristics were compared between PMs and other WHO grade 1 meningiomas...
March 29, 2024: Journal of Neurosurgery
https://read.qxmd.com/read/38527168/four-distinct-ipsilateral-vestibular-schwannomas-a-case-of-mosaic-nf2-related-schwannomatosis
#25
JOURNAL ARTICLE
Alexandra E Tunkel, Emily R Youner, Hayk Barseghyan, Yulong Fu, Surajit Bhattacharya, Miriam Bornhorst, Ashkan S Monfared
OBJECTIVES: Distinguishing between sporadic and germline/mosaic NF2-related schwannomatosis is important to ensure that patients have appropriate long-term care. With this report, we describe a unique case of a patient with 4 ipsilateral schwannomas and identify a combination of sequencing modalities that can accurately diagnose mosaic NF2-related schwannomatosis. METHODS: We present a 32-year-old woman with a familial history of vestibular schwannoma in her father and right-sided schwannomas involving the apical and basal turns of cochlea, lateral semicircular canal, and internal auditory canal (IAC)...
March 25, 2024: American Journal of Clinical Pathology
https://read.qxmd.com/read/38522513/the-tumor-suppressor-nf2-modulates-tead4-stability-and-activity-in-hippo-signaling-via-direct-interaction
#26
JOURNAL ARTICLE
Mengying Wu, Liqiao Hu, Lingli He, Liang Yuan, Lingling Yang, Bin Zhao, Lei Zhang, Xiaojing He
As an output effector of the Hippo signaling pathway, the TEAD transcription factor and co-activator YAP play crucial functions in promoting cell proliferation and organ size. The tumor suppressor NF2 has been shown to activate LATS1/2 kinases and interplay with the Hippo pathway to suppress the YAP-TEAD complex. However, whether and how NF2 could directly regulate TEAD remains unknown. We identified a direct link and physical interaction between NF2 and TEAD4. NF2 interacted with TEAD4 through its FERM domain and C-terminal tail and decreased the protein stability of TEAD4 independently of LATS1/2 and YAP...
March 22, 2024: Journal of Biological Chemistry
https://read.qxmd.com/read/38521834/the-impact-of-mental-health-on-health-related-quality-of-life-in-patients-with-nf2-related-schwannomatosis
#27
JOURNAL ARTICLE
Anna Freier, Anna C Lawson McLean, Denise Loeschner, Steffen K Rosahl, Johannes Kruse
NF2-related schwannomatosis (NF2-SWN) is a rare genetic disorder and is associated with progressive morbidities. This study aimed to investigate the relationship between NF2-SWN disease severity, health-related Quality of Life (QoL), and mental health aspects of patients. Standardised questionnaires assessing mental health problems (symptoms of depression, anxiety, and somatic burden), psychological factors (resilience, loneliness, and personality functioning), and health-related QoL were administered to 97 patients with NF2-SWN...
March 23, 2024: Scientific Reports
https://read.qxmd.com/read/38506024/-neurofibromatosis-type-2-in-the-otorhinolaryngological-practice
#28
JOURNAL ARTICLE
M V Subbotina, A V Berseneva
Neurofibromatosis type 2 (NF2) is a rare autosomal dominant disease (frequency 1 in 25-90 000) characterized by the formation of tumors of the central nervous system due to a mutation in the NF2 gene on chromosome 22q12. Bilateral vestibular schwannomas are recognized as absolute diagnostic criteria of NF2 and occur in 95% of patients, are accompanied by hearing impairment, manifest at the age of 18-24 years. Skin manifestations can precede vestibular schwannomas for several years and predict the course of the disease: neurofibromas, cafe-au-lait macules, hypopigmented spots, recently described mesh capillary malformations...
2024: Vestnik Otorinolaringologii
https://read.qxmd.com/read/38504181/rna-binding-proteins-potentially-regulate-the-alternative-splicing-of-apoptotic-genes-during-knee-osteoarthritis-progression
#29
JOURNAL ARTICLE
Zheng Zhang, Limei Dong, Hai Tao, Yusong Dong, Wei Xiang, Fenghua Tao, Yingchun Zhao
BACKGROUND: Alternative splicing (AS) is a principal mode of genetic regulation and one of the most widely used mechanisms to generate structurally and functionally distinct mRNA and protein variants. Dysregulation of AS may result in aberrant transcription and protein products, leading to the emergence of human diseases. Although considered important for regulating gene expression, genome-wide AS dysregulation, underlying mechanisms, and clinical relevance in knee osteoarthritis (OA) remain unelucidated...
March 19, 2024: BMC Genomics
https://read.qxmd.com/read/38482961/cochlear-implantation-in-neurofibromatosis-type-2-related-schwannomatosis-long-term-hearing-outcomes
#30
JOURNAL ARTICLE
Baptiste Grenier, Isabelle Mosnier, Evelyne Ferrary, Yann Nguyen, Olivier Sterkers, Michel Kalamarides, Ghizlene Lahlou, Hannah Daoudi
OBJECTIVE: To evaluate long-term hearing outcomes following cochlear implantation in patients with neurofibromatosis type 2 and ipsilateral vestibular schwannoma. STUDY DESIGN: Retrospective study. SETTING: Tertiary general hospital. METHODS: Twenty-two patients undergoing cochlear implantation between 2004 and 2018 with at least 1 year of follow-up were included. Patients were categorized as "users" or "nonusers" of their cochlear implant (CI)...
March 14, 2024: Otolaryngology—Head and Neck Surgery
https://read.qxmd.com/read/38482423/-nf2-is-a-candidate-diagnosis-prognostic-and-immunotherapeutic-biomarker-a-systematic-pan-cancer-analysis
#31
JOURNAL ARTICLE
Honglu Zhang, Jiyong Liu
BACKGROUND: Neurofibromin 2 ( NF2 ) regulates diverse cellular events such as transcription, translation, ubiquitination, and micro-RNA biosynthesis. Previous evidence revealed that aberrant expression of NF2 contributes to tumorigenesis in mesothelioma, meningioma, and breast cancer. However, there is no comprehensive pan-cancer analysis to explore NF2 's function in cancer diagnosis, prognosis, and immunological prediction. METHODS: By extensive use of data profiles from The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx) project, Cancer Cell Line Encyclopedia (CCLE), CIBERSORT, Human Protein Atlas (HPA), and cBioPortal, we employed various bioinformatics methods to explore the role of NF2 in pan-cancer, including analyzing the association between NF2 and tumor diagnosis, prognosis, immune cell infiltration, tumor mutational burden (TMB), and microsatellite instability (MSI)...
February 29, 2024: Translational Cancer Research
https://read.qxmd.com/read/38476930/preclinical-evaluation-of-the-third-generation-bi-steric-mechanistic-target-of-rapamycin-complex-1-selective-inhibitor-rmc-6272-in-nf2-deficient-models
#32
JOURNAL ARTICLE
Srirupa Bhattacharyya, Janet L Oblinger, Roberta L Beauchamp, Lili Kosa, Francis Robert, Scott R Plotkin, Long-Sheng Chang, Vijaya Ramesh
BACKGROUND: NF2-associated meningiomas are progressive, highly morbid, and nonresponsive to chemotherapies, highlighting the need for improved treatments. We have established aberrant activation of the mechanistic target of rapamycin (mTOR) signaling in NF2 -deficient tumors, leading to clinical trials with first- and second-generation mTOR inhibitors. However, results have been mixed, showing stabilized tumor growth without shrinkage offset by adverse side effects. To address these limitations, here we explored the potential of third-generation, bi-steric mTOR complex 1 (mTORC1) inhibitors using the preclinical tool compound RMC-6272...
2024: Neuro-oncology advances
https://read.qxmd.com/read/38473416/dynamic-survival-risk-prognostic-model-and-genomic-landscape-for-atypical-teratoid-rhabdoid-tumors-a-population-based-real-world-study
#33
JOURNAL ARTICLE
Sihao Chen, Yi He, Jiao Liu, Ruixin Wu, Menglei Wang, Aishun Jin
BACKGROUND: An atypical teratoid/rhabdoid tumor (AT/RT) is an uncommon and aggressive pediatric central nervous system neoplasm. However, a universal clinical consensus or reliable prognostic evaluation system for this malignancy is lacking. Our study aimed to develop a risk model based on comprehensive clinical data to assist in clinical decision-making. METHODS: We conducted a retrospective study by examining data from the Surveillance, Epidemiology, and End Results (SEER) repository, spanning 2000 to 2019...
March 5, 2024: Cancers
https://read.qxmd.com/read/38463125/a-rare-case-of-schwannomatosis-with-meningioma-a-case-report
#34
Saurav Neupane, Ashutosh Kashyap, Shreeram Paudel, Ganesh Bhattarai, Santosh K Kharel, Asim Adhikari, Ashim Ghimire, Simankan Pokharel, Pratibha Yadav, Krishna K Yadav
INTRODUCTION: Schwannomatosis is characterized by multiple schwannomas without vestibular schwannomas or any other stigmata of neurofibromatosis type 2 (NF2). Schwannomatosis is a rare disorder, with a reported incidence ranging from 1 in 40 000 to 1 in 1.7 million. Meningioma is also associated with schwannomatosis in around 5% of cases. CASE PRESENTATION: We describe a case of a 20-year-old female presenting with progressive weakness of the right lower limb for 7 months with a tingling sensation and numbness of the same limb for 6 months and was found to have schwannomatosis with multiple spinal and right cerebellopontine angle (CPA) (9th/10th cranial nerve) schwannomas and left anterior cranial fossa meningioma...
March 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38458050/a-dft-study-on-regulating-the-active-center-of-v-ti-2-xt-2-mxene-through-surface-modification-for-efficient-nitrogen-fixation
#35
JOURNAL ARTICLE
Yu Xiong, Yaqin Zhang, Yuhang Wang, Ninggui Ma, Jun Zhao, Shuang Luo, Jun Fan
The electrochemical conversion of nitrogen to ammonia provides an encouraging method to substitute the traditional Haber-Bosch process, owing to its high efficiency and mild reaction conditions. The search for high-performance catalysts and comprehension of catalytic mechanisms remains significant challenges. Herein, we conduct a systematic theoretical calculation of the NRR performance and mechanism of 24 Ti2 XT2 (X = B, C, N; T = F, Cl, Br, I, O, S, Se, Te) MXenes with a T-vacancy to explore the influence of surface functional terminations and non-metallic center elements...
March 5, 2024: Journal of Colloid and Interface Science
https://read.qxmd.com/read/38451298/an-unusual-finding-of-an-anaplastic-meningioma-in-nf2-related-schwannomatosis
#36
JOURNAL ARTICLE
Siegfried J Adelhoefer, James Feghali, Sharika Rajan, Charles G Eberhart, Verena Staedtke, Alan R Cohen
NF2-related schwannomatosis (NF2) is a rare autosomal-dominant genetic disorder characterized by bilateral vestibular schwannomas and multiple meningiomas. This case report presents the extremely rare occurrence of an anaplastic meningioma in a 12-year-old male with previously undiagnosed NF2. The patient presented with a history of abdominal pain and episodic emesis, gait unsteadiness, right upper and lower extremity weakness, and facial weakness. He had sensorineural hearing loss and wore bilateral hearing aids...
March 7, 2024: Child's Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery
https://read.qxmd.com/read/38451296/incidence-of-tethered-cord-syndrome-in-neurofibromatosis-types-1-and-2-pediatric-patients-a-population-level-analysis
#37
JOURNAL ARTICLE
Debarati Bhanja, Zachary Freedman, Bao Y Sciscent, Camille Moeckel, Lekhaj Daggubati, Elias Rizk
PURPOSE: Tethered spinal cord syndrome (TCS) is characterized by cutaneous attachments on the filum terminale that stretch the spinal cord, leading to musculoskeletal and urogenital sequelae. While the neurocutaneous associations with TCS remain undefined, a recent study reports a high incidence of TCS among a pediatric neurofibromatosis (NF) cohort. This present study utilizes a population-level database to estimate TCS incidence among pediatric patients with neurofibromatosis types 1 and 2 (NF1, NF2)...
March 7, 2024: Child's Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery
https://read.qxmd.com/read/38443692/cutaneous-toxicities-of-mitogen-activated-protein-kinase-inhibitors-in-children-and-young-adults-with-neurofibromatosis-1
#38
JOURNAL ARTICLE
Brianna C Peacock, Sanjna Tripathy, Hannah L Hanania, Hannah Y Wang, Zsila Sadighi, Anisha B Patel
PURPOSE: Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder which commonly causes neoplasms leading to disfigurement or dysfunction. Mitogen-activated protein kinase inhibitors (MEKi) are generally well-tolerated treatments which target neural tumor progression in patients with NF1. However, cutaneous adverse events (CAEs) are common and may hinder patients' abilities to remain on treatment, particularly in children. We aim to characterize CAEs secondary to MEKi treatment in pediatric and young adult patients with NF1...
March 5, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38438584/lncrna-snhg5-mediates-activation-of-hepatic-stellate-cells-by-regulating-nf2-and-hippo-pathway
#39
JOURNAL ARTICLE
Rongrong Zhang, Yating Zhan, Zhichao Lang, Yifei Li, Weizhi Zhang, Jianjian Zheng
Long noncoding RNA small nucleolar RNA host gene 5 (SNHG5) is an oncogene found in various human cancers. However, it is unclear what role SNHG5 plays in activating hepatic stellate cells (HSCs) and liver fibrosis. In this study, SNHG5 was found to be upregulated in activated HSCs in vitro and in primary HSCs isolated from fibrotic liver in vivo, and inhibition of SNHG5 suppressed HSC activation. Notably, Neurofibromin 2 (NF2), the main activator for Hippo signalling, was involved in the effects of SNHG5 on HSC activation...
March 4, 2024: Communications Biology
https://read.qxmd.com/read/38437842/unilateral-multifocal-inner-ear-and-internal-auditory-canal-or-cerebellopontine-angle-cochleovestibular-schwannomas-genetic-analysis-and-management-by-surgical-resection-and-cochlear-implantation
#40
JOURNAL ARTICLE
Stefan K Plontke, Katrin Hoffmann, Per Caye-Thomasen, Sevjidmaa Baasanjav, Sabrina Kösling, Sandra Leisz, Arne Liebau, Christian Mawrin, Torsten Rahne, Jonas Scheffler, Christian Strauss, Udo Siebolts
OBJECTIVE: To describe the genetic characteristics and the management of two very rare cases of unilateral multifocal inner ear and internal auditory canal or cerebellopontine angle cochleovestibular schwannomas not being associated to full neurofibromatosis type 2-related schwannomatosis. PATIENTS: In a 29-year-old man and a 55-year-old woman with single-sided deafness multifocal unilateral cochleovestibular schwannomas were surgically resected, and hearing was rehabilitated with a cochlear implant (CI)...
March 4, 2024: Otology & Neurotology
keyword
keyword
77364
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.